Parkside Financial Bank & Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.35K | Sell |
12
-11
| -48% | -$3.17K | ﹤0.01% | 1948 |
|
|
2025
Q4 | $6.97K | Buy |
23
+6
| +35% | +$1.87K | ﹤0.01% | 1703 |
|
|
2025
Q3 | $4.77K | Hold |
17
| – | – | ﹤0.01% | 1749 |
|
|
2025
Q2 | $4.1K | Buy |
17
+3
| +21% | +$709 | ﹤0.01% | 1772 |
|
|
2025
Q1 | $3.41K | Sell |
14
-2
| -13% | -$602 | ﹤0.01% | 1746 |
|
|
2024
Q4 | $5.26K | Sell |
16
-5
| -24% | -$1.7K | ﹤0.01% | 1437 |
|
|
2024
Q3 | $7.03K | Sell |
21
-14
| -40% | -$4.45K | ﹤0.01% | 1354 |
|
|
2024
Q2 | $9.56K | Sell |
35
-46
| -57% | -$13.4K | ﹤0.01% | 1197 |
|
|
2024
Q1 | $28K | Buy |
81
+34
| +72% | +$11.2K | ﹤0.01% | 930 |
|
|
2023
Q4 | $15.2K | Sell |
47
-1
| -2% | -$313 | ﹤0.01% | 1050 |
|
|
2023
Q3 | $17.2K | Sell |
48
-14
| -23% | -$5.4K | ﹤0.01% | 951 |
|
|
2023
Q2 | $23.5K | Buy |
62
+24
| +63% | +$9.77K | 0.01% | 831 |
|
|
2023
Q1 | $18.2K | Buy |
38
+4
| +12% | +$1.87K | ﹤0.01% | 901 |
|
|
2022
Q4 | $14.3K | Buy |
34
+9
| +36% | +$3.63K | ﹤0.01% | 944 |
|
|
2022
Q3 | $10K | Sell |
25
-29
| -54% | -$14.5K | ﹤0.01% | 984 |
|
|
2022
Q2 | $26K | Buy |
54
+24
| +80% | +$12.5K | 0.01% | 732 |
|
|
2022
Q1 | $17K | Sell |
30
-19
| -39% | -$11.5K | ﹤0.01% | 871 |
|
|
2021
Q4 | $37K | Buy |
49
+8
| +20% | +$5.99K | 0.01% | 614 |
|
|
2021
Q3 | $31K | Buy |
41
+2
| +5% | +$1.5K | 0.01% | 640 |
|
|
2021
Q2 | $25K | Hold |
39
| – | – | 0.01% | 702 |
|
|
2021
Q1 | $22K | Hold |
39
| – | – | 0.01% | 738 |
|
|
2020
Q4 | $23K | Hold |
39
| – | – | 0.01% | 674 |
|
|
2020
Q3 | $20K | Hold |
39
| – | – | 0.01% | 637 |
|
|
2020
Q2 | $18K | Sell |
39
-8
| -17% | -$3.53K | 0.01% | 663 |
|
|
2020
Q1 | $16K | Sell |
47
-20
| -30% | -$7.35K | 0.01% | 605 |
|
|
2019
Q4 | $25K | Buy |
67
+19
| +40% | +$6.7K | 0.01% | 594 |
|
|
2019
Q3 | $16K | Buy |
48
+40
| +500% | +$13K | 0.01% | 675 |
|
|
2019
Q2 | $3K | Sell |
8
-2
| -20% | -$599 | ﹤0.01% | 1058 |
|
|
2019
Q1 | $3K | Sell |
10
-59
| -86% | -$15.9K | ﹤0.01% | 1059 |
|
|
2018
Q4 | $16K | Buy |
69
+7
| +11% | +$1.88K | 0.01% | 624 |
|
|
2018
Q3 | $19K | Buy |
62
+43
| +226% | +$13.3K | 0.01% | 616 |
|
|
2018
Q2 | $5K | Sell |
19
-8
| -30% | -$2.21K | ﹤0.01% | 864 |
|
|
2018
Q1 | $7K | Hold |
27
| – | – | ﹤0.01% | 787 |
|
|
2017
Q4 | $6K | Sell |
27
-8
| -23% | -$1.94K | ﹤0.01% | 818 |
|
|
2017
Q3 | $8K | Sell |
35
-9
| -20% | -$2.02K | ﹤0.01% | 768 |
|
|
2017
Q2 | $10K | Hold |
44
| – | – | ﹤0.01% | 731 |
|
|
2017
Q1 | $9K | Sell |
44
-9
| -17% | -$1.73K | ﹤0.01% | 722 |
|
|
2016
Q4 | $10K | Hold |
53
| – | – | ﹤0.01% | 696 |
|
|
2016
Q3 | $9K | Sell |
53
-1
| -2% | -$152 | ﹤0.01% | 735 |
|
|
2016
Q2 | $8K | Hold |
54
| – | – | ﹤0.01% | 730 |
|
|
2016
Q1 | $7K | Hold |
54
| – | – | ﹤0.01% | 719 |
|
|
2015
Q4 | $7K | Hold |
54
| – | – | ﹤0.01% | 718 |
|
|
2015
Q3 | $7K | Buy |
+54
| New | +$7.77K | ﹤0.01% | 712 |
|
Other funds holding BIO
VCM
VPM
AI
Parkside Financial Bank & Trust's BIO Position: Q1 2026 in Review
Parkside Financial Bank & Trust reduced its Bio-Rad Laboratories Class A (BIO) stake by 48% in Q1 2026, selling an estimated $3.17K and leaving 12 shares worth $3.35K. The position accounts for ﹤0.01% of the portfolio, ranked #1948.
Parkside Financial Bank & Trust first reported a position in BIO in Q3 2015 and has held it in 43 quarters since. The position peaked at $37K in Q4 2021. 391 funds tracked by Wall St. Rank hold BIO as of Q1 2026.
- Parkside Financial Bank & Trust held 12 shares of Bio-Rad Laboratories Class A worth $3.35K as of Q1 2026.
- Parkside Financial Bank & Trust sold 11 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $3.17K.
- Bio-Rad Laboratories Class A made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1948 holding.
- Parkside Financial Bank & Trust first reported a position in Bio-Rad Laboratories Class A in Q3 2015 and has held it in 43 quarters since.
- Parkside Financial Bank & Trust's Bio-Rad Laboratories Class A position peaked at $37K in Q4 2021.
- 391 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.